Cite
Neuron-restrictive silencer factor-mediated downregulation of μ-opioid receptor contributes to the reduced morphine analgesia in bone cancer pain.
MLA
Chao Zhu, et al. “Neuron-Restrictive Silencer Factor-Mediated Downregulation of μ-Opioid Receptor Contributes to the Reduced Morphine Analgesia in Bone Cancer Pain.” PAIN, vol. 158, no. 5, May 2017, pp. 879–90. EBSCOhost, https://doi.org/10.1097/j.pain.0000000000000848.
APA
Chao Zhu, Jun Tang, Tan Ding, Lei Chen, Wei Wang, Xiao-Peng Mei, Xiao-Tao He, Wen Wang, Li-Dong Zhang, Yu-Lin Dong, Zhuo-Jing Luo, Zhu, C., Tang, J., Ding, T., Chen, L., Wang, W., Mei, X.-P., He, X.-T., Wang, W., & Zhang, L.-D. (2017). Neuron-restrictive silencer factor-mediated downregulation of μ-opioid receptor contributes to the reduced morphine analgesia in bone cancer pain. PAIN, 158(5), 879–890. https://doi.org/10.1097/j.pain.0000000000000848
Chicago
Chao Zhu, Jun Tang, Tan Ding, Lei Chen, Wei Wang, Xiao-Peng Mei, Xiao-Tao He, et al. 2017. “Neuron-Restrictive Silencer Factor-Mediated Downregulation of μ-Opioid Receptor Contributes to the Reduced Morphine Analgesia in Bone Cancer Pain.” PAIN 158 (5): 879–90. doi:10.1097/j.pain.0000000000000848.